HeartBeam, Inc.

NasdaqCM BEAT

HeartBeam, Inc. Price to Sales Ratio (P/S) on January 14, 2025

HeartBeam, Inc. Price to Sales Ratio (P/S) is NA on January 14, 2025, a NA change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.

HeartBeam, Inc. 52-week high Price to Sales Ratio (P/S) is NA on January 14, 2025, which is NA below the current Price to Sales Ratio (P/S).
HeartBeam, Inc. 52-week low Price to Sales Ratio (P/S) is NA on January 14, 2025, which is NA below the current Price to Sales Ratio (P/S).
HeartBeam, Inc. average Price to Sales Ratio (P/S) for the last 52 weeks is NA.

Key data

Date	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield

NasdaqCM: BEAT

HeartBeam, Inc.

CEO	Mr. Robert P. Eno
IPO Date	Nov. 11, 2021
Location	United States
Headquarters	2118 Walsh Avenue
Employees	15
Sector	Health Care
Industries Telehealth Medical Instruments

Description

HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiogram machine and a cloud-based diagnostic software system to address the rapidly growing field of remote patient monitoring. The company was incorporated in 2015 and is headquartered in Santa Clara, California.

Key trends

Past 5 years